Patent details

Basic Information

Publication number:

LUC00361

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP212000053

Legal Status:

Pending & Published

Application number:

LUC00361

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/24/1838

Marketing Authorization Type:

Marketing Authorization Date:

26/07/2024

Marketing Authorization Status:

Claimed

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

28/10/2024

First Marketing Authorization date:

26/07/2024

Grant date:

Activation date:

Publication date:

04/11/2024

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

15/09/2034

SPC Extension Expiration:

15/09/2034

Rejection date:

Withdrawal date:

Owner

From:

28/10/2024

 

 

Name:

uniQure biopharma B.V.

Address:

Paasheuvelweg 25a, 1105 BP Amsterdam, Netherlands (NL)

Agent

Name:

Dennemeyer & Associates S.A.

From:

28/10/2024

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2024/14

Publication date:

06/12/2024

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Other

Note:

Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant

Filing date	Document type	Number of pages
28/10/2024	General Document	1
28/10/2024	Application Form	6
28/10/2024	Marketing authorization	3
04/11/2024	Outgoing Correspondence	1
28/10/2024	Summary of the product caracteristics	55
28/10/2024	MA publication	12
04/11/2024	Publication	1
27/01/2025	Administration	1
30/07/2025	Outgoing Correspondence	2
30/07/2025	Incoming Correspondence (Email)	2
30/07/2025	General Document	1
30/07/2025	General Document	2
06/08/2025	Outgoing Correspondence	1